Exosome Diagnostics Release: Leading Liquid Biopsy Company, Exosome Diagnostics, Appoints John Boyce As Chief Executive Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics, the developer of a leading liquid biopsy platform that enables non-invasive diagnosis of disease states, potentially obviating the need for tissue biopsy, has announced the appointment of John Boyce as its Chief Executive Officer.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC